From Name

From Email

To Name

To Email

Message

Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities

from Medicinal Research Reviews

Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities Medicinal Research Reviews Despite the applicability of histone deacetylase inhibitors (HDACis) for cancer treatment, several works in the literature have shown that these inhibitors can be used in several other diseases, such as neurodegenerative diseases (NDs). This review begins by discussing the signaling pathways of HDACs, focused on the context of NDs, presenting a discussion about the pharmacophoric features of HDACis and crystal structure analysis and discussing interesting case studies from the literature about the development of HDACis. READ MORE

more